| Updated:
Best of the Brokers for 18 July 2014
To appear in Best of the Brokers, email your research to notes@cityam.com
ROYAL MAIL
Beaufort Securities has upgraded the mail group to “buy” from “hold”, with a target price at 560p. The broker believes Royal Mail continues to exhibit steady operational performance, with growth in the European and UK parcel market providing a strong opportunity for the group.
HIKMA PHARMACEUTICALS
UBS has increased to “buy” from “neutral”, raising the target price to 2,000p from 1,700p. The broker believes that the acquisition of Bedford Laboratories is a good deal that makes strategic and financial sense for Hikma, with another acquisition likely ahead to diversify geographically.